473 related articles for article (PubMed ID: 15156315)
21. Anti-diabetic and anti-inflammatory effect of a novel selective 11β-HSD1 inhibitor in the diet-induced obese mice.
Park SB; Jung WH; Kang NS; Park JS; Bae GH; Kim HY; Rhee SD; Kang SK; Ahn JH; Jeong HG; Kim KY
Eur J Pharmacol; 2013 Dec; 721(1-3):70-9. PubMed ID: 24135201
[TBL] [Abstract][Full Text] [Related]
22. Depot-specific messenger RNA expression of 11 beta-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults.
Li X; Lindquist S; Chen R; Myrnäs T; Angsten G; Olsson T; Hernell O
Int J Obes (Lond); 2007 May; 31(5):820-8. PubMed ID: 17060929
[TBL] [Abstract][Full Text] [Related]
23. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
[TBL] [Abstract][Full Text] [Related]
24. Alteration of 11beta-hydroxysteroid dehydrogenase type 1 in skeletal muscle in a rat model of type 2 diabetes.
Zhang M; Lv XY; Li J; Xu ZG; Chen L
Mol Cell Biochem; 2009 Apr; 324(1-2):147-55. PubMed ID: 19118409
[TBL] [Abstract][Full Text] [Related]
25. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.
Tomlinson JW; Sinha B; Bujalska I; Hewison M; Stewart PM
J Clin Endocrinol Metab; 2002 Dec; 87(12):5630-5. PubMed ID: 12466364
[TBL] [Abstract][Full Text] [Related]
26. Weight loss after gastric bypass surgery in women is followed by a metabolically favorable decrease in 11beta-hydroxysteroid dehydrogenase 1 expression in subcutaneous adipose tissue.
Simonyte K; Olsson T; Näslund I; Angelhed JE; Lönn L; Mattsson C; Rask E
J Clin Endocrinol Metab; 2010 Jul; 95(7):3527-31. PubMed ID: 20410231
[TBL] [Abstract][Full Text] [Related]
27. Association between 11beta-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in Bosnian population.
Dujic T; Bego T; Mlinar B; Semiz S; Malenica M; Prnjavorac B; Ostanek B; Marc J; Causevic A
Biochem Med (Zagreb); 2012; 22(1):76-85. PubMed ID: 22384521
[TBL] [Abstract][Full Text] [Related]
28. The cortisol-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 in skeletal muscle in the pathogenesis of the metabolic syndrome.
Loerz C; Maser E
J Steroid Biochem Mol Biol; 2017 Nov; 174():65-71. PubMed ID: 28765040
[TBL] [Abstract][Full Text] [Related]
29. Association of HSD11B1 gene polymorphisms with type 2 diabetes and metabolic syndrome in South Indian population.
Devang N; Satyamoorthy K; Rai PS; Nandini M; Rao S; Phani NM; Adhikari P
Diabetes Res Clin Pract; 2017 Sep; 131():142-148. PubMed ID: 28750217
[TBL] [Abstract][Full Text] [Related]
30. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss.
Engeli S; Böhnke J; Feldpausch M; Gorzelniak K; Heintze U; Janke J; Luft FC; Sharma AM
Obes Res; 2004 Jan; 12(1):9-17. PubMed ID: 14742837
[TBL] [Abstract][Full Text] [Related]
31. Effects of a high-salt diet on adipocyte glucocorticoid receptor and 11-beta hydroxysteroid dehydrogenase 1 in salt-sensitive hypertensive rats.
Usukura M; Zhu A; Yoneda T; Karashima S; Yagi K; Yamagishi M; Takeda Y
Steroids; 2009 Nov; 74(12):978-82. PubMed ID: 19646461
[TBL] [Abstract][Full Text] [Related]
32. Differences in associations between HSD11B1 gene expression and metabolic parameters in subjects with and without impaired glucose homeostasis.
Karlsson C; Jernås M; Olsson B; Lystig T; Gummesson A; Storlien L; Groop L; Carlsson B
Diabetes Res Clin Pract; 2010 Jun; 88(3):252-8. PubMed ID: 20381186
[TBL] [Abstract][Full Text] [Related]
33. Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes.
Nakano S; Inada Y; Masuzaki H; Tanaka T; Yasue S; Ishii T; Arai N; Ebihara K; Hosoda K; Maruyama K; Yamazaki Y; Shibata N; Nakao K
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1213-22. PubMed ID: 17190905
[TBL] [Abstract][Full Text] [Related]
34. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
Masuzaki H; Flier JS
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
[TBL] [Abstract][Full Text] [Related]
35. A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome.
Gambineri A; Tomassoni F; Munarini A; Stimson RH; Mioni R; Pagotto U; Chapman KE; Andrew R; Mantovani V; Pasquali R; Walker BR
Eur J Endocrinol; 2011 Aug; 165(2):283-92. PubMed ID: 21622477
[TBL] [Abstract][Full Text] [Related]
36. Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans.
Stimson RH; Andersson J; Andrew R; Redhead DN; Karpe F; Hayes PC; Olsson T; Walker BR
Diabetes; 2009 Jan; 58(1):46-53. PubMed ID: 18852329
[TBL] [Abstract][Full Text] [Related]
37. Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians.
Lindsay RS; Wake DJ; Nair S; Bunt J; Livingstone DE; Permana PA; Tataranni PA; Walker BR
J Clin Endocrinol Metab; 2003 Jun; 88(6):2738-44. PubMed ID: 12788882
[TBL] [Abstract][Full Text] [Related]
38. 7-oxysterols modulate glucocorticoid activity in adipocytes through competition for 11beta-hydroxysteroid dehydrogenase type.
Wamil M; Andrew R; Chapman KE; Street J; Morton NM; Seckl JR
Endocrinology; 2008 Dec; 149(12):5909-18. PubMed ID: 18755798
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes.
Tagawa N; Kubota S; Kato I; Kobayashi Y
J Endocrinol; 2013 Sep; 218(3):311-20. PubMed ID: 23814014
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes.
Abdallah BM; Beck-Nielsen H; Gaster M
Eur J Clin Invest; 2005 Oct; 35(10):627-34. PubMed ID: 16178882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
